Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes: Research Summary
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Lipoproteins and Cardiovascular Health
Diabetes
Cardiovascular Risks
and Lipoproteins
Atherosclerosis and Cardiovascular Diseases
Publication details
- Journal / source
- JAMA
- Volume
- 335
- Issue
- 16
- Pages
- e263429–e263429
- Publication date
- 28 March 2026
- Language
- EN